Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The unidentified reticulocyte receptor recognized by Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) is a host cell surface protein essential for the invasion of human reticulocytes by the malaria parasite. While PvAMA-1 is well-known for its interaction with the parasite-derived protein RON2 to form a moving junction, recent evidence indicates it also binds directly to a host receptor on the reticulocyte membrane. This interaction is critical for the initial attachment and reorientation of the merozoite during the invasion process. Targeting this receptor-ligand interaction with monoclonal antibodies or vaccines is a major strategy for developing blood-stage malaria interventions. Although the exact molecular identity of this host receptor has historically been unknown, recent research has identified KREMEN1 as a functional receptor for AMA-1 across multiple Plasmodium species, including P. vivax. Its role in the strict tropism of P. vivax for immature red blood cells makes it a high-priority therapeutic target for preventing clinical malaria symptoms.
Blocking the interaction between PvAMA-1 and its host receptor prevents the formation of the moving junction and inhibits the invasion of reticulocytes by Plasmodium vivax merozoites.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unidentified reticulocyte receptor recognized by PvAMA-1.